Low-dose cyclophosphamide enhances helper-to-non-helper ratios
A Sardi1, C Agnone, G Anderson
1Department of Surgery, Ochsner Clinic, New Orleans, LA 70121.
Cancer Detection and Prevention
|January 1, 1991
Summary
Cyclophosphamide (CY) impacts rat lymphocyte populations in a dose-dependent manner. Lower CY doses showed a temporary immunostimulatory effect without causing illness, unlike higher doses.
Area of Science:
- Immunology
- Pharmacology
- Toxicology
Background:
- Cyclophosphamide (CY) is an alkylating agent used in chemotherapy and immunosuppression.
- Understanding its effects on lymphocyte populations is crucial for therapeutic applications and safety assessments.
Purpose of the Study:
- To investigate the dose-dependent effects of cyclophosphamide on T and B lymphocyte populations in rats.
- To evaluate the impact of cyclophosphamide on the helper-to-non-helper T cell ratio and animal weight.
Main Methods:
- F-344 Fisher rats were administered varying doses of cyclophosphamide (25, 50, 75 mg/kg) or a control.
- Lymphocyte populations (T lymphocytes, T helper, non-helper T, and B lymphocytes) were analyzed using monoclonal antibodies.
- Blood samples were collected on days 0, 3, 7, and 14 post-administration.
- Body weight changes were monitored throughout the study.
Main Results:
- Lymphocyte depletion was dose-related and affected both helper and non-helper T cells (p < 0.02).
- A transient increase in the helper-to-non-helper T cell ratio was observed on day 3 in the lowest dose group (25 mg/kg).
- Rats receiving lower doses of CY maintained or gained weight, while those receiving higher doses lost weight (p < 0.05).
Conclusions:
- Cyclophosphamide exerts a dose-dependent effect on lymphocyte populations in rats.
- Lower doses of cyclophosphamide may induce a temporary immunostimulatory effect with minimal morbidity.
- Higher doses of cyclophosphamide lead to significant lymphocyte depletion and weight loss, indicating toxicity.
